the only reason they listed on the asx was because of the listing rules and lack of reg demands IMHO.this stock is for the US and AIM markets not oz, 100% agree with bartm
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%